Wuhan Keqian Biology Co.,Ltd (SHA:688526)

SHA:688526 Revenue

Wuhan Keqian Biology Co.,Ltd had revenue of 227.54M CNY in the quarter ending March 31, 2026, a decrease of -7.20%. This brings the company's revenue in the last twelve months to 932.09M, down -5.10% year-over-year. In the year 2025, Wuhan Keqian Biology Co.,Ltd had annual revenue of 949.74M with 0.83% growth.

• Revenue (ttm): 932.09M
• Revenue Growth: -5.10%
• P/S Ratio: 7.48
• Revenue / Employee: 981.15K
• Employees: 950
• Market Cap: 6.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	949.74M	7.82M	0.83%
Dec 31, 2024	941.92M	-122.15M	-11.48%
Dec 31, 2023	1.06B	62.81M	6.27%
Dec 31, 2022	1.00B	-101.75M	-9.22%
Dec 31, 2021	1.10B	259.79M	30.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error